| |
|
|
|
Oramed Pharmaceuticals Inc.  
|
|
3.55 0.05 (0.01%) |
06-17 16:00 |
|
Open: |
3.51 |
Pre close: |
3.5 |
Target:
|
4.38
|
|
High: |
3.61 |
Low: |
3.5 |
Resistance:
|
3.75
4.38
|
|
Volume: |
8,457 |
Market Cap: |
62M |
Support:
|
3.17
2.81
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.55
 |
MACD |
MACD(12,26):
|
0.05 |
|
MA(20): |
3.20 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
3.41 |
Stochastic Oscillator |
%K(14,3):
|
76.24  |
|
MA(250): |
4.19 |
%D(3): |
81.01 |
|
Average Volume(K) |
3-Month: |
7972
|
52-Week |
High:
|
7.84 |
|
10-Days: |
3221 |
Low: |
2.78 |
|
RSI |
RSI(14):
|
61.06 |
Change(%): |
-51.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.860 |
Return on Equity (ttm) |
-68.8 |
Shares Out. (M) |
17.38 |
|
EPS Est. Current Year |
-0.780 |
Return on Assets (ttm) |
-39.4 |
Shares Float (M) |
17.38 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.270 |
Qtrly Rev. Growth |
10.3 |
% Held by Institutions |
11.60 |
|
Forward EPS |
-1.521 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.240 |
EBITDA (p.s.) |
0.000 |
P/E |
-4.13 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.58 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-14.47 |
P/S |
385618752.00 |
|
Operating Margin |
-617.41 |
Levered Free Cash Flow
(M) |
-9.09 |
P/CF |
-4.26 |
|
|
|
|
|
|
